IBSA present their new approach to achieve harmonious results in the lips 

It never occurs to us that lips play a truly distinctive role: they turn emotions of all intensities into unique expressions that speak volumes about us. The increase in the demand for lip treatments coincides with the desire and urge to enhance their uniqueness. For this reason, IBSA Derma, the dermo-aesthetic division of IBSA Farmaceutici, with its expertise in the field of aesthetic medicine and in the production of ultrapure hyaluronic acid, is proposing Aliaxin® EgoLips, a new approach that highlights not only the lips’ harmonious volumes and shapes but also their uniqueness, guaranteeing adequate tissue integration1.

According to the American Society of Plastic Surgeons2, 2.6 million procedures were performed in 2018 alone, with an increase of 312% between 2000 and 2017. This trend is also being driven by Millennials (+30.6%), who start requesting lip treatments as early as the age of 20. Social media and overexposure to the digital mirror (Zoom-boom) have contributed in bringing about increased focus on the care of one’s image, which in turn helps boost self-confidence, as well as greater awareness and acceptance of dermo-aesthetic procedures, thus overcoming associated taboos.

IBSA Derma’s approach aims at preserving authentic beauty by building on patients’ desires (EGO), seeking to defend individual expressiveness (inner beauty) while at the same time respecting the symmetry of each person’s features (shape). 

To quote Dr Riccardo Forte, who contributed to the clinical part of the protocols, ‘Patients’ demands have become increasingly specific and sophisticated, also among the very young. Aliaxin® EgoLips is an integrated project that supports practitioners, in terms of product quality and innovative techniques, in obtaining a customized result, thus offering a practical tool for their everyday practice as well as an asset for communication with patients.’

Essential protocol

  • Product: Aliaxin® FL                                    
  • Result: lip gloss effect
  • Technique: Single step. Retrograde drop with Aliaxin® FL in the submucosal layer

Global protocol

  • Product: Aliax® LV + Aliaxin® FL
  • Result: verticality + softness
  • Combined technique: 2 optional steps (T2 2 weeks after T1). Verticalizing pillars with Aliaxin® LV in the submucosal layer + retrograde drop technique with Aliaxin® FL in the deep submucosal layer (between muscle and mucosa)

Outstanding protocol

  • Product: Aliax® LV + Aliaxin® FL
  • Result: volume sculpting + eye catching
  • Combined technique: 2 steps required. Restructuring pillars with Aliaxin® LV in the submucosal layer and retrograde drop technique with Aliaxin® FL in the deep submucosal layer (between muscle and mucosa).

IBSA Derma boasts consolidated scientific know-how, acquired through ongoing collaborations with professionals of international standing and is present with its treatments in almost 70 countries worldwide.

  For more information, visit


  1. Lip Augmentation Market Size, Share & Trends Analysis Report By Type (Temporary, Permanent), By Product (Hyaluronic Acid Fillers, Poly-L-Lactic Acid Fillers), By Region, And Segment Forecasts, 2020 – 2027. Availabe at: https://www.grandviewresearch.com/industry-analysis/lip-augmentation-market [last accessed 10 March 2022] 
  2. A. La Gatta et al. Biophysical and biological characterization of a new line of hyaluronan-based dermal filler: A scientific rationale to specific clinical indications. Materials Science and Engineering C 68 (2016) 565-572